CARSGEN THERAPEUTICS HLDGS LTD
(HKEX: 2171)
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The firm focuses on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. The company was founded by Zong Hai Li and Hua Mao Wang on February 9, 2018, and is headquartered in Shanghai, China.
8.420 -
-0.270
(-3.11%)
Range
8.410 - 8.870
(5.47%)
Open
8.870
Previous Close
8.690
Bid Price
8.420
Bid Volume
('000)
95
Ask Price
8.450
Ask Volume
('000)
49.5
Volume
('000)
6,420
Value
54,830,990
Remark
-
Delayed prices. Updated at 20 Dec 2024 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
